{
 "drug": "Cisatracurium Besylate Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "05/06/2026",
 "dayN": 111,
 "cat": "Analgesia/Addiction",
 "companies": [
  "Hospira, Inc., a Pfizer Company"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "05/06/2026",
   "update_type": "New",
   "initial_posting_date": "05/06/2026",
   "package_ndc": "0409-1103-01",
   "generic_name": "Cisatracurium Besylate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA203236"
    ],
    "brand_name": [
     "CISATRACURIUM BESYLATE"
    ],
    "generic_name": [
     "CISATRACURIUM BESYLATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1103",
     "0409-1098",
     "0409-1208"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CISATRACURIUM BESYLATE"
    ],
    "rxcui": [
     "199211",
     "199212",
     "1730194"
    ],
    "spl_id": [
     "7b64e51a-1a55-4949-ac7c-b0a21cbd6ec9"
    ],
    "spl_set_id": [
     "67908e20-044d-454d-9c51-bf106e817bd0"
    ],
    "package_ndc": [
     "0409-1098-12",
     "0409-1098-02",
     "0409-1103-11",
     "0409-1103-01",
     "0409-1208-11",
     "0409-1208-01"
    ],
    "unii": [
     "80YS8O1MBS"
    ]
   },
   "update_date": "05/06/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Cisatracurium Besylate, Injection, 200 mg/20ml (10 mg/mL) Single Dose Vial (NDC 0409-1103-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "05/06/2026",
   "update_type": "New",
   "initial_posting_date": "05/06/2026",
   "package_ndc": "0409-1208-01",
   "generic_name": "Cisatracurium Besylate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA203238"
    ],
    "brand_name": [
     "CISATRACURIUM BESYLATE"
    ],
    "generic_name": [
     "CISATRACURIUM BESYLATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1208",
     "0409-1098",
     "0409-1103"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CISATRACURIUM BESYLATE"
    ],
    "rxcui": [
     "199211",
     "199212",
     "1730194"
    ],
    "spl_id": [
     "7b64e51a-1a55-4949-ac7c-b0a21cbd6ec9"
    ],
    "spl_set_id": [
     "67908e20-044d-454d-9c51-bf106e817bd0"
    ],
    "package_ndc": [
     "0409-1098-12",
     "0409-1098-02",
     "0409-1103-11",
     "0409-1103-01",
     "0409-1208-11",
     "0409-1208-01"
    ],
    "unii": [
     "80YS8O1MBS"
    ]
   },
   "update_date": "05/06/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Cisatracurium Besylate, Injection, 20 mg/10 mL (2 mg/mL) Multidose Vial (NDC 0409-1208-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  }
 ]
}